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Abstract
Introduction. Contingency management interventions are among the most efficacious psychosocial interventions in promot-
ing abstinence from smoking, alcohol and substance use. The aim of this study was to assess the beliefs and objections towards
contingency management among patients in UK-based drug and alcohol services to help understand barriers to uptake and
support the development and implementation of these interventions. Methods. The Service User Survey of Incentives was
developed and implemented among patients (N = 181) at three UK-based drug and alcohol treatment services. Descriptive
analyses were conducted to ascertain positive and negative beliefs about contingency management, acceptability of different tar-
get behaviours, incentives and delivery mechanisms including delivering incentives remotely using technology devices such as
mobile telephones. Results. Overall, 81% of participants were in favour of incentive programs, with more than 70% of
respondents agreeing with the majority of positive belief statements. With the exception of two survey items, less than a third of
participants agreed with negative belief statements. The proportion of participants indicating a neutral response was higher for
negative statements (27%) indicating greater levels of ambiguity towards objections and concerns regarding contingency man-
agement. Discussion and Conclusions. Positive beliefs towards contingency management interventions were found,
including high levels of acceptability towards a range of target behaviours, incentives and the use of technology devices to
remotely monitor behaviour and deliver incentives. These findings have implications for the development and implementation
of remote contingency management interventions within the UK drug treatment services. [Getty C-A, Weaver T, Lynskey
M, Kirby KC, Dallery J, Metrebian N. Patients’ beliefs towards contingency management: Target behaviours,
incentives and the remote application of these interventions. Drug Alcohol Rev 2021]
Key words: contingency management, substance use, acceptability, beliefs, survey.
Introduction
Contingency management (CM) interventions, based
on the scientific principles of operant conditioning,
involve the application of positive reinforcement con-
tingent upon behaviour change. CM is among the
most efficacious psychosocial interventions in promot-
ing abstinence from smoking, alcohol and illicit drugs
[1–7]. While CM has a strong evidence base, accept-
ability of these interventions among staff and patients
is vital. Capturing their views and attitudes can support
CMs implementation into routine service provision,
ensuring the development and delivery of interventions
that are consistent with patients’ and staff’s idea of
appropriate treatment.
While prior research, predominately surveying treat-
ment providers in the USA, demonstrates support for
CM with the majority endorsing favourable opinions
towards these interventions [8,9], several concerns
have been highlighted. These include issues related to
the practicality of implementing CM, lack of sustained
treatment effects and economic evaluations, and ethi-
cal objections towards the use of financial incentives to
reinforce behaviour change [8–14]. These factors
might be impeding the uptake and implementation of
CM within clinical practice in the UK and
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international addiction services and need to be
addressed prior to implementation efforts.
In addition, patients’ beliefs towards CM have not
been widely investigated. Research has been limited to
surveys examining acceptability of study procedures
among patients in receipt of CM in the USA [15–19]
and a small UK-based qualitative investigation [20].
These studies found that patients view CM as a moti-
vating and positive tool to facilitate recovery and the
monitoring of behaviours and financial incentives are
strengths of the intervention [16]. However, these
beliefs are most likely to be affected by multiple con-
textual factors. For example, there are many differ-
ences between the UK and US health-care systems
and understanding acceptability among patients within
UK substance use services might further illuminate
beliefs in a UK-specific context. Additionally, it will be
helpful to assess if patient’s beliefs and objections
towards CM are associated with different patient char-
acteristics (e.g. length of time in treatment and age) as
associations between positive beliefs and several char-
acteristics of treatment providers have previously been
found [8,21].
The use of technology to facilitate the application of
CM to improve health-related behaviours such as
abstinence is a growing area of research [22]. Remote
applications of CM have been developed to enhance
the reach of these interventions, enabling patients to
stay in contact with services when engagement is vari-
able or intermittent over a long period [23]. Technol-
ogy might optimise the application of reinforcement
principles, monitoring and reinforcing the target
behaviour more frequently than is otherwise possible
[22,24]. A meta-analysis of mobile telephone-delivered
CM [25] and more recent evaluation studies [19,26–
30] suggest these interventions are effective in generat-
ing positive behaviour change. However, the platforms
upon which these interventions can be implemented
might vary in their appropriateness or acceptability to
the patient population. Research exploring patients’
acceptability towards these modern modalities (which
are typically automated with limited human interac-
tion) has been confined to explorations of acceptability
among participants in the context of existing studies in
the USA [31–33].
The aim of this study was to explore beliefs towards
CM among patients receiving treatment for substance
use disorders (SUD) in UK addiction services. Spe-
cific objectives included assessing: beliefs and objec-
tions towards CM; acceptability of social and tangible
rewards; acceptability of targeting different substance
related behaviours; and acceptability of using technol-
ogy to remotely monitor behaviour and deliver incen-
tives. The associations between patient characteristics
and beliefs were also explored.
Method
Participants
Participants were patients receiving treatment for SUDs
in three London drug services. The clinics are managed
by the South London & Maudsley National Health Ser-
vice Foundation Trust who provides the widest range of
National Health Service mental health services in the
UK, offering specialist in-clinic and outpatient services
to help patients with SUD in reducing or stopping their
use and minimising the associated harm. Participants
were eligible to take part if they were receiving treat-
ment, fluent in English and over the age of 18.
Procedure
Patients were approached by the researcher while
waiting in the clinic reception for their appointment,
informed about the study and provided with an infor-
mation sheet. Following informed consent, the ques-
tionnaire was provided to the participant and completed
at the clinic (with the researcher if requested). To
encourage participation, entry to a prize draw to win a
£50 gift voucher was offered.
Service User Survey of Incentives
The questionnaire was created in collaboration with the
author of the Provider Survey of Incentives (PSI): a
44-item scale assessing beliefs held by treatment providers
regarding CM [8]. The research team created a pool of
question items from the PSI and rated each item for impor-
tance on a 5-point scale. Overlapping items and those rated
as low importance to service users were removed. Question
items were selected based on their relevance to a patient
population and those specific to health-care providers were
omitted. Language was modified for a UK patient group.
Authors of the PSI indicated that the structure of the ques-
tionnaire of asking the same questions for social and tangi-
ble incentives separately could have created a contrast
effect, such that one type of incentive would be favoured
over the other. This limitation was taken into consideration
and tangible incentives were focused on. The Service User
Survey of Incentives (SUSI) was developed, consisting of
18-items categorised into four themes: limitations of incen-
tive programs, ethical/moral objections, negative side effects
and positive opinions regarding incentives.
The questionnaire consisted of four parts and pro-
vided a brief description of CM to ensure participants
were aware of its key features, including frequency and
delivery of the reinforcer contingent on objective verifi-
cation of the target behaviour. Part A contained two
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questions to measure awareness and experience of CM
incentives. Part B contained the 18-item SUSI to
ascertain beliefs and objections towards CM. Part C
contained five sets of questions: two specific to atti-
tudes towards different types of rewards and target
behaviours, while three questions were specific to the
remote application of CM. Participants were required
to indicate their level of agreement with each survey
item on a 5-point Likert scale [(strongly) disagree,
neutral, (strongly) agree]. Part D contained questions
regarding basic demographics and treatment history.
Data analysis
The proportion of participants indicating agreement,
disagreement or neutral responses to the individual
items were calculated for descriptive purposes. Items
on the SUSI were categorised according to the four
themes: positive beliefs (items 1, 3, 5, 10, 11, 12,
15, 16, 17 and 18), limitations of incentive programs
(items 6, 9 and 14), ethical/moral objections (items
2, 7 and 8) and negative side effects (items 4 and 13)
with summary scores pooled for descriptive purposes.
Variables were recoded, grouping levels of agreement
(strongly disagree/disagree and strongly agree/agree) to
aid comparison across items and subscales.
Positive and negative belief items were grouped, sum-
mary scores calculated and associations with participant
characteristics explored. Reliability analyses were carried
out on the two subscales to assess the internal validity
and appropriateness of congregating survey items.
Cronbach’s alpha showed the positive beliefs subscale
(10 items: 1, 3, 5, 10, 11, 12, 15, 16, 17, 18) and the
negative beliefs subscale (8 items: 2, 4, 6, 7, 8, 9, 13, 14)
reached good reliability; α = 0.88, α = 0.79, respectively.
Inter-item correlations indicated that all items are worthy
of retention, resulting in a decrease in the alpha if
deleted. Missing values were coded as missing in SPSS
and analyses were conducted using the available data.
Participants were divided by age, and into four
groups based on their length of time in treatment:
(<1 year, 1–5 years, 5–10 years, >10 years). Pearson
chi-square analyses examined associations between
awareness and experience of CM, specific participant
characteristics and the repeated dependent variable
(SUSI subscale score) to determine if they were associ-
ated with differences in beliefs.
Ethical considerations
The project received ethical approval from the London
Chelsea National Health Service Research Ethics
Committee (19/LO/1590).
Results
Participant demographics and substance use characteristics
Participants (N = 181) were recruited between
November 2019 and March 2020. Participants were
male (63%), White (74%), with a median age of
45 years (interquartile range 53–37). Participants were
currently receiving treatment for a range of substances,
heroin (54%) and alcohol (39%) being the two most
reported. Time in treatment ranged from 1 month to
50 years (median 5, interquartile range 15–0.9)
(Table 1).
Mobile phone ownership
Mobile phone ownership was high (96%). Of those, 85%
owned smartphones and 56% had a monthly contract
plan, while 27% reported to changing their mobile num-
ber in the last year. Most participants (94%) reported that
they would be comfortable with their treatment provider
contacting them on their mobile phone, but only 31% said
they would be comfortable with the use of geo-location for
treatment purposes.
Awareness and experience of incentive interventions
Overall, 33% of participants reported being aware of
CM interventions. However, only 8% reported they
had experienced it.
Positive and negative beliefs towards CM
Table 2 shows the percentages of participants indicat-
ing agreement, disagreement or neutral responses to
individual survey items.
Positive beliefs. Overall, high proportions of partici-
pants agreed with statements expressing positive beliefs
regarding CM, with 81% indicating that they would be
‘in favour of incentive programmes’. With the exception
of 2 of the 10 survey items, over 70% of respondents
agreed with all positive belief statements. Statements
that were among the most highly endorsed were that
‘incentives are useful if they reward service users for ful-
filling health care goals…’ and ‘incentives are more
likely to have positive effects… than they are to have
negative effects’. Less endorsed statements included
‘incentives are good for the service user-recovery worker
relationship’ and ‘incentives can be useful whether or
not they address the underlying reasons for engaging in
unhealthy behaviour’, with 65% and 48% of
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participants respectively indicating agreement. The pro-
portion of participants indicating a neutral response
across the survey items averaged 17%.
Negative beliefs. With the exception of two survey items,
less than 30% of participants agreed with negative belief
statements. While more than 50% of participants disagreed
with only three out of eight negative statements, 27% of
participants indicated a neutral response, suggesting greater
levels of ambiguity about objections towards CM.
The most frequently endorsed negative belief state-
ment was that ‘incentives are most useful for short-term
purposes…’ with 38% agreeing with this statement.
Statements pertaining to ethical and moral concerns
were among the least endorsed. Only 11% of partici-
pants agreed with the statement ‘incentives are offensive
to me because they are a bribe’. Other statements
expressing ethical concerns about the appropriateness
of incentives (incentives ‘…conflicts with my idea of
appropriate treatment’ and ‘it is not right to give incen-
tives to service users for what they should be doing…’)
received modest endorsement, with 26% and 20%
respectively agreeing with these statements.
Statements alluding to the negative side effects of CM
were among the most supported negative items. Twenty-
eight percent of participants agreed with the statement
‘incentives will stop the service user from realising their
internal motivation to engage in healthy behaviours’. The
second most endorsed negative belief (32%) was that
‘most service users would sell or exchange incentives …
[and] use the money to engage in substance use’.
Acceptability towards CM mechanisms
Table 3 shows the percentages of participants indicat-
ing agreement, disagreement or neutral responses to
each individual item.
Table 1. Participant characteristics
Variable Median (IQR) N (%)
Age, years 45 (53–37)
Gender Male 114 (63%)
Female 67 (37%)










Accommodation status Owner occupied 17 (9.7%)
Rented private 53 (30.1%)
Rented (LA, HA) 73 (41.5%)
Living with parents/relatives 17 (9.7%)
B&B/hotel 2 (1.1%)
Hostel 5 (2.8%)
NFA (living on the streets) 6 (3.4%)
Other 3 (1.7%)
Length of time in treatment
for SUD in the UK
5 (15–0.9)
Substance(s) receiving treatment for (multiple
substances could be indicated)
Tobacco 20 (11.1%)
Cannabis 28 (15.6%)









HA, housing association; IQR, interquartile range; LA, local authority; NFA, no fixed abode.
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Acceptability of tangible and social incentives. Service
vouchers (e.g. gym passes) were rated as most accept-
able (84%), followed by retail vouchers (74%), social
incentives (71%), prize draws (62%) and clinical privi-
leges (55%). Cash incentives were least accept-
able (33%).
Table 2. Percentage of participants agreeing with Provider Survey of Incentives items
Strongly




1 Incentives are worthwhile because they can get
reluctant service users in the door for treatment.
1.1 6.1 20.4 44.2 28.2
3 Incentives are good for the service user–recovery
worker relationship.
2.8 5.5 26.5 45.3 19.9
5 Incentives are more likely to have positive effects
on the service user than they are to have negative
effects.
0.6 4.4 18.8 53.0 23.2
10 I would be in favour of incentives to build healthy
behaviours for service users.
0.6 6.6 11.0 53.0 28.7
11 Incentives are useful if they reward service users
for fulfilling a health-care goal, such as attending
appointments, engaging in physical exercise, or
taking medication as prescribed.
1.1 5.0 7.2 57.5 29.3
12 An advantage of incentive programs is that they
focus on what is ‘good’ in the service user’s
behaviour (e.g. treatment compliance, drug free
urines/abstinence), not what they did ‘wrong’ (e.g.
not making recommended lifestyle changes).
1.1 4.4 18.2 51.9 24.3
15 Incentives can be useful whether or not they
address the underlying reasons for engaging in
unhealthy behaviour.
3.9 17.7 30.9 38.1 9.4
16 Incentives can be useful in building healthy
behaviours (e.g. physical exercise, healthy eating).
0.6 5.0 12.7 58.0 23.8
17 Incentives can be useful in reducing unhealthy
behaviours (e.g. substance abuse).
1.1 13.3 12.7 53.6 19.3
18 Overall, I would be in favour of service user
incentive programs.
2.2 6.1 11.0 44.8 35.9
Negative beliefs
2 It is not right to give incentives to service users for
what they should be doing in the first place.
19.3 37.6 23.2 16.6 3.3
4 Incentives will stop the service user from realising
their internal motivation to engage in healthy
behaviours.
10.5 34.3 27.6 21.5 6.1
6 It is not useful to give service users incentives
because positive behaviour change will last only as
long as the incentives are given.
11.6 37.0 29.3 17.7 4.4
7 Giving incentives on a consistent and ongoing
basis conflicts with my idea of appropriate
treatment.
13.3 34.8 26.0 21.5 4.4
8 Incentives are offensive to me because they are a
bribe.
29.8 43.1 16.0 8.3 2.8
9 There are enough rewards in being healthy;
incentives are not necessary.
14.4 39.8 22.7 17.7 5.5
13 Most service users would sell or exchange
incentives (e.g. shop vouchers) they receive for
cash, and then use the money to engage in
substance use.
10.5 23.8 34.3 23.8 7.7
14 Incentives are most useful for short-term purposes
(e.g. encouraging smoking cessation for several
weeks prior to surgery; increasing appropriate use
of antibiotics).
5.5 17.1 39.2 32.0 6.1
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Acceptability of target behaviours. Most participants
responded that it was acceptable for CM to target non-
substance use behaviours such as attendance (75%) and
adherence to medications (69%). Levels of acceptability
towards CM targeting substance use varied depending
on substance, from 62% for cannabis use to 71% for
alcohol use. While less than 14% deemed targeting any
substance unacceptable, 22% of participants indicated
neutral responses, suggesting a level of uncertainty.
Acceptability of different modes of delivery. The results
indicate significantly high levels of acceptability (78%)
towards the use of electronic devices to monitor behav-
iour. As many as 81% and 74% thought it appropriate
to monitor a reduction or cessation of substances using
a breathalyser or medication compliance using an elec-
tronic pill dispenser. Although the majority deemed it
more acceptable to receive social (92%) and tangible
(80%) incentives in person, remote delivery via phone
call (77%), text message (73%) or reloadable debit
card (62%) were also acceptable. In contrast, delivery
of tangible incentives in the post was acceptable to
only a bare majority (51%).
Associations between participant characteristics and beliefs
regarding CM
No association was found between awareness or expe-
rience of CM, age or length of time in treatment and
positive or negative beliefs (Table 4).
Discussion
Our study found that 81% of patients in treatment for
SUD in UK addiction services are in favour of CM
interventions. Our findings suggest that patients
Table 3. Percentage of participants agreeing with additional survey items. Arranged in order of acceptability
Strongly




Service vouchers (e.g. gym pass, travel card) 1.7 3.3 11.0 45.3 38.7
Retail vouchers (e.g. supermarket vouchers) 3.9 7.7 14.4 42.5 31.5
Social incentives (e.g. praise, certificates) 2.2 7.2 19.3 40.3 30.9
Prize draw entry (i.e. chance to win a prize) 6.1 8.3 23.2 36.5 26.0
Clinical privileges (e.g. take-home methadone
doses)
11.0 11.6 22.1 34.3 21.0
Cash 30.4 21.0 16.0 22.7 9.9
Acceptable target behaviours
Attendance at the clinic 3.3 5.0 17.1 49.7 24.9
Alcohol use 5.0 5.0 18.8 46.4 24.9
Adherence to prescribed medications 3.9 6.1 21.5 46.4 22.1
Stimulant use (e.g. cocaine, amphetamines) 5.5 7.2 21.0 45.9 20.4
Nicotine use 7.2 6.6 20.4 44.2 21.5
Non-prescribed opiate use (e.g. heroin, codeine,
morphine)
5.0 7.2 22.2 42.2 23.3
Cannabis use 5.0 5.5 27.6 44.2 17.7
Acceptable monitoring devices
Breathalyser to verify reduced alcohol
consumption
1.7 4.4 10.0 58.3 25.6
Breath carbon monoxide to verify smoking
cessation
2.8 6.1 13.3 53.6 24.3
Electronic device (i.e. tablet, computer, mobile
phone) to record attendance at the clinic
2.8 7.2 12.2 55.2 22.7
Electronic pill dispenser to verify medication
consumption
2.8 6.6 16.6 53.0 21.0
Acceptable delivery of social reinforcement
In person 1.1 2.2 5.0 38.1 53.6
By phone call 3.3 5.5 14.4 44.2 32.6
By text message 5.5 9.9 11.6 42.0 30.9
Acceptable delivery of tangible reinforcement
In person 4.4 3.9 12.2 42.0 37.6
On a reloadable debit card (provided by the
clinic)
7.2 9.9 21.0 39.2 22.7
In the post 7.7 16.6 24.9 32.6 18.2
6 C.-A. Getty et al.
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believe CM could be useful in building healthy behav-
iours (e.g. attendance) and reducing unhealthy
behaviours (e.g. substance use). Although limited
research has been conducted to examine patients’
beliefs towards CM, our findings are consistent with
those examining acceptability towards study proce-
dures among patients in receipt of CM [15–18].
Among objections commonly held by treatment pro-
viders is that it is unethical to ‘pay people for what they
should be doing anyway’ [14], however we found little
support for this concern among participants. While
half of our participants agreed ‘incentives can be useful
whether or not they address the underlying reasons for
engaging in unhealthy behaviours’, a modest propor-
tion agreed that ‘incentives will stop the service user
from realising their internal motivation to engage in
healthy behaviours’. This was one of the biggest con-
cerns among our sample and one that might pose sig-
nificant barriers to the uptake of CM among patients.
Health-care providers also report concern about the
impact CM may have on the therapeutic relationship
[15]. Although some suggest CM can strengthen this
relationship others argue that it could negatively
impact the development and sustainability of it, by
shifting the focus from the treatment needs of the indi-
vidual to monitoring behaviours and delivery of mone-
tary reward [34]. While we found some uncertainty
reflected by around a quarter offering a ‘neutral’
response, 65% agreed that ‘incentives are good for the
service user-recovery worker relationship’. Future
investigations must explore this critical issue and care-
fully consider the way in which incentives are provided
to participants and by whom.
Our study allowed us to explore patients’ acceptance
of the use of tangible and social incentives. This insight
is key in the development of CM interventions to
ensure the reward is appropriate and meaningful.
While retail and service vouchers were acceptable to
most, 51% of participants disagreed with the use of
cash. Previous research suggests that cash may be
more effective than voucher-based reinforcers and par-
ticipants utilise their incentives responsibly [35,36].
Therefore, it is essential that objections towards the
use of cash incentives are addressed effectively. How-
ever, it is possible that presenting a range of tangible
and social incentives concurrently created a contrast
effect. While a similar effect was found in the original
study utilising the PSI tool [8], and this was consid-
ered in the development of the SUSI, future research
should do more to minimise this impact.
Furthermore, moderate levels of support were found
for targeting abstinence, with alcohol use being most
endorsed. Worth noting however, is that around one in
five patients indicated neutral responses (22%),
suggesting some level of uncertainty. It is plausible to
assume that patients demonstrating negligible
Table 4. Chi-squared associations between positive and negative beliefs towards CM and participant characteristics










Yes 57 (97%) 2 (3%) 35 (59%) 24 (41%)
No 118 (97%) 4 (3%) x2(1) = 0.002, P = 0.969 79 (59%) 50 (41%) x2(1) = 0.002, P = 0.969
Experience of CM
Yes 14 (100%) 0 (0%) 12 (86%) 2 (14%)
No 161 (96%) 6 (4%) x2(1) = 0.520, P = 0.471 95 (57%) 72 (43%) x2(1) = 4.42, P = 0.035a
Age, years
20–30 19 (95%) 1 (5%) 11 (55%) 9 (45%)
30–40 43 (98%) 1 (2%) 30 (68%) 14 (32%)
40–50 57 (97%) 2 (3%) 35 (59%) 28 (41%)
50–60 41 (100%) 0 (0%) 19 (46%) 22 (54%)
60–74 11 (85%) 2 (15%) x2(4) = 7.476, P = 0.113 10 (77%) 3 (23%) x2(4) = 6.118, P = 0.191
Length of time in treatment
<1 year 53 (95%) 3 (5%) 38 (68%) 18 (32%)
1–5 years 43 (98%) 1 (2%) 26 (59%) 18 (41%)
5–10 years 27 (96%) 1 (4%) 18 (64%) 10 (36%)
10+ years 51 (98%) 1 (2%) x2(3) = 1.191, P = 0.755 25 (48%) 27 (52%) x2(3) = 4.706, P = 0.195
aThere was some evidence that people with experience of contingency management differed from those with no experience of
contingency management in terms of their negative beliefs in Chi-square analyses, although not in logistic regression and confi-
dence intervals indicated low precision (odds ratio 4.547, 95% confidence interval 0.987–20.958). CM, contingency
management.
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acceptability towards CM are more likely to report less
support to targeting behaviour change. Despite this
ambiguity, a small number of patients indicated that
targeting any substance would be unacceptable. Con-
versely, encouraging non-substance use behaviours
were reported to be more acceptable, with more than
two thirds of participants deeming it appropriate. This
is important, as CM targeting these behaviours can have
a positive impact on reducing substance use [37,38].
The empirical findings from this study are the first
to shed light on patients’ attitudes towards the use of
technological devices including mobile telephones to
deliver CM. The findings allow us to understand how
patients perceive remote applications of CM and their
acceptability towards these modalities which are typi-
cally automated with limited human interaction. Our
findings suggest that patients consider it acceptable to
use devices such as breathalysers to monitor treatment
behaviours or verify a reduction in substance use.
Modest levels of acceptability towards the use of tech-
nology (e.g. mobile telephones) to monitor behaviour
and deliver reinforcement were also found. These find-
ings are pertinent in the development of remote CM
interventions, as they suggest patients’ recognition of
the importance to ensure objective measurement and
verification of the target behaviour. With mobile
telephone-delivered CM demonstrating potential effec-
tiveness in encouraging abstinence and 96% of patients
currently owning a mobile telephone, using this plat-
form to extend the reach of CM within a UK setting
may be more possible than ever before.
Study strengths
This study not only provides novel insight into the
beliefs and objections held by patients towards CM,
but sheds light on patients’ acceptance of the use of
remote technological devices to monitor behaviour and
deliver reinforcement. Assessing perceived beliefs
and objections towards technology-based CM among
non-recipients provides an important perspective and
eliminates biases associated with conducting accept-
ability assessments with individuals already enrolled
and engaging with a CM intervention. Furthermore,
the SUSI tool was developed in collaboration with the
PSI author, selecting items based on their relevance to
a patient population and modifying the language to
ensure appropriate for a UK audience. As the original
PSI consisting of 44 items was deemed too lengthy
and cumbersome for our target group making it diffi-
cult to implement, the SUSI consisted of 18 items.
The SUSI tool demonstrated high levels of internal
consistency and reliability, warranting its use and
application for future studies examining beliefs held
regarding CM interventions.
Study limitations
Despite successfully capturing a range of patients receiv-
ing treatment for drugs and alcohol, our sample cannot
be representative of all UK patients receiving substance
use treatment and thus caution should be taken when
interpreting findings. Furthermore, the samples were
those currently in treatment for SUD, indicating some
degree of engagement with their treatment. Future explo-
rations should examine beliefs held among individuals
outside of London and those not in treatment for SUD
who might offer a different perspective.
Our findings also indicate a high proportion of par-
ticipants selected a ‘neutral’ response to negative belief
statements, indicating frequent ambiguity. The inter-
pretation of neutral responses presents considerable
challenges as one might select a neutral response when
they believe the question is not relevant to them or
they do not feel they have enough information to make
an informed choice. Another plausible explanation
could be difficulty in understanding the terminology
used in the SUSI tool. Although this would not have
disadvantaged the majority, patient consultations in
the development phase could have helped ensure the
SUSI tool was suitable for a range of educational abili-
ties. Furthermore, previous literature has highlighted
the impact limited understanding of CM has on beliefs
and objections among treatment providers [21].
Although our study found no evidence to support the
association between beliefs and experience with CM,
the number of participants with prior experience might
have been too small for differences to be detected.
Further investigations with larger samples sizes would
enable us to explore how beliefs might differ by demo-
graphic group. Additionally, it was not possible to
assess associations between substance receiving treat-
ment for and levels of acceptability towards CM, how-
ever future research should consider this, given that
treatment outcomes differ by type of substance.
Conclusion
This study is the first to assess patients’ beliefs towards
CM and the acceptability of delivering these interven-
tions remotely using technology among patients in
treatment for SUD. These findings not only highlight
the most prevalent objections and concerns that may
impact upon uptake of CM, but also indicate that most
patients are accepting of these interventions. However,
future research must address several key issues
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highlighted by this study. Addressing objections
towards the use of cash incentives is imperative in
ensuring these interventions are acceptable to the
patient population. Future surveys should consider
the addition of open-ended qualitative questions to
enable participants to indicate their reasoning and
motivations for their particular beliefs and objections
towards CM. Furthermore, future research should uti-
lise larger sample size to examine beliefs held among
other patient groups, including those not in treatment
for SUD; patients outside of London; and those with
prior experience of CM interventions. Despite no asso-
ciation being found between experience of CM and
beliefs held about these interventions, previous litera-
ture has indicated the role awareness and experience of
CM plays in generating positive attitudes towards these
interventions and therefore efforts should be made to
promote understanding of these treatments and the
integration of such in UK clinical practice. Finally,
remote CM and mobile CM specifically, may offer a
potentially useful means of engaging those individuals
who are particularly difficult to treat due to comorbid-
ity and polysubstance use, and therefore their develop-
ment and implementation within UK drug treatment
services should be given serious consideration.
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